This is a preview of subscription content, log in via an institution to check access.
References
PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Peramivir hydrate. Internet Document : 18 Oct 2016. Available from: URL: http://www.pmda.go.jp/files/000214573.pdf.
PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Daptomycin. Internet Document : 2 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000214572.pdf.
PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Nivolumab (genetical recombination). Internet Document : 18 Oct 2016. Available from: URL: http://www.pmda.go.jp/files/000214571.pdf.
PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Ustekinumab (genetical recombination). Internet Document : 18 Oct 2016. Available from: URL: http://www.pmda.go.jp/files/000214570.pdf.
PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Warfarin potassium and azole antifungal drugs (oral, injections). Internet Document : 18 Oct 2016. Available from: URL: http://www.pmda.go.jp/files/000214569.pdf.
PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Fluvastatin sodium, pravastatin sodium, simvastatin, atorvastatin calcium hydrate, pitavastatin calcium hydrate, rosuvastatin calcium, amlodipine besilate/atorvastatin calcium hydrate. Internet Document : 18 Oct 2016. Available from: URL: http://www.pmda.go.jp/files/000214568.pdf.
Rights and permissions
About this article
Cite this article
PMDA releases six summary of investigation results. Reactions Weekly 1626, 6 (2016). https://doi.org/10.1007/s40278-016-22587-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-22587-x